Evidence map›Paper›PMID 17599703›Full record

ReviewNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics2007

Iron in chronic brain disorders: imaging and neurotherapeutic implications.

James Stankiewicz, S Scott Panter, Mohit Neema, Ashish Arora, Courtney E Batt, Rohit Bakshi

Open access · bronzeAbstract readReview
In one paragraph

Review in Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 120 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
120citing papers in PubMed, 1 pooled it
11.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

120 citing papers in PubMed, 1 synthesis or guideline pooled it, 303 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. One-Year Substantia NigraMovement disorders : official journal of the Movement Disorder Society · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Neurodegeneration with Brain Iron Accumulation.Advances in experimental medicine and biology · 2025
    Review
  15. Article
  16. Article
  17. Article
  18. A missense mutation in theFrontiers in neuroscience · 2024
    Article
  19. Article
  20. Article

60 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

James StankiewiczDepartment of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA.
S Scott Panter
Mohit Neema
Ashish Arora
Courtney E Batt
Rohit Bakshi
Brigham and Women's Hospital · USHarvard University · USNeurological Surgery · US

Funding

MRI T2 shortening ('blackT2') in multiple sclerosisK23NS042379 · NINDS · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI BAKSHI, ROHIT · 2001 to 2003
$375k
NINDS NIH HHS 1 K23 NS42379-01NINDS NIH HHS K23 NS042379
6 · The paper itself

Abstract

Iron is important for brain oxygen transport, electron transfer, neurotransmitter synthesis, and myelin production. Though iron deposition has been observed in the brain with normal aging, increased iron has also been shown in many chronic neurological disorders including Alzheimer's disease, Parkinson's disease, and multiple sclerosis. In vitro studies have demonstrated that excessive iron can lead to free radical production, which can promote neurotoxicity. However, the link between observed iron deposition and pathological processes underlying various diseases of the brain is not well understood. It is not known whether excessive in vivo iron directly contributes to tissue damage or is solely an epiphenomenon. In this article, we focus on the imaging of brain iron and the underlying physiology and metabolism relating to iron deposition. We conclude with a discussion of the potential implications of iron-related toxicity to neurotherapeutic development.

Indexed as

Magnetic Resonance ImagingAnimalsBrainHumansIronIron Metabolism DisordersNeurodegenerative DiseasesIron

Identifiers

PMID17599703
PMCPMC1963417
OpenAlexW2021177193

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.